T. Rowe Price Value
(TRVLX)
+0.35
+1.11%
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 31.54 |
| Category | Large Value |
| Net Assets | 14.96 Bil |
| Yield | 1.45% |
| Morningstar Risk | Above Average |
| Morningstar Return | Above Average |
- Last NAV update 5/17/2013 4:00 PM ET
| NA |
|---|
| The investment seeks long-term capital appreciation; income is a secondary consideration. In taking a value approach to investment selection, at least 65% of total assets will normally be invested in common stocks the portfolio manager regards as undervalued. Holdings are expected to consist primarily of large-cap stocks, but may also include stocks of mid-cap and small-cap companies. While most assets will typically be invested in U.S. common stocks, the fund may invest in foreign stocks in keeping with the fund's objectives. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | 37.15% | 15.96% | -2.00% | 19.46% | 20.89% |
| Value ($) | 13,715.00 | 15,903.91 | 15,585.83 | 18,618.83 | 22,508.30 |
- Year to date performance as of 5/16/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | T. Rowe Price |
| Fund Manager | Mark Finn |
| Tenure (Years) | 3 |
| Fund Status | Open |
| Minimum Initial Purchase | 2,500.00 |
| Minimum IRA Investment | 1,000.00 |
| Front Load | 0.00 |
| Expense Ratio | 0.85% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 8.14% |
| 3 Months | 11.23% |
| 1 Year | 40.24% |
| 3 Years* | 16.33% |
| 5 Years* | 6.49% |
- * Annualized returns
- Performance as of 5/16/2013 8:00 PM ET
| TRVLX | Large Value | |
|---|---|---|
| 5-Yr Return | 6.49% | 3.95% |
| Sharpe Ratio | 0.76 | 0.77 |
| Net Assets | 14.96 Bil | 603.81 Mil |
| Avg Market Cap | 42.52 Bil | 44.23 Bil |
| Avg P/E | 15.48 | 12.71 |
| Portfolio Turnover | 56 | 92 |
| Symbol | Value ($) |
|---|---|
| Stocks | 97.85% |
| Cash | 1.98% |
| Fixed Income | 0.00% |
| Other | 0.17% |
| NAME | % NET ASSETS |
|---|---|
| Pfizer Inc | 4.94% |
| JPMorgan Chase & Co | 3.96% |
| AT&T Inc | 3.21% |
| Merck & Co Inc | 3.07% |
| Johnson & Johnson | 2.64% |
| Procter & Gamble Co | 2.32% |
| Phillips 66 | 2.09% |
| MetLife Inc | 2.05% |
| Cisco Systems Inc | 1.91% |
| International Paper Co. | 1.87% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
